Some are workflow upgrades for the medicine we already have. Some are entire clinical practices that didn't have a name yet because the substrate didn't support them.
Six representative Monday-morning workflows for people inside the system. Each is the same medicine, with a different substrate underneath.
Eight directions reachable from the substrate that today don't have a name in medicine — because the substrate didn't support them.
Wearable sensors writing to your substrate produce a continuous baseline of your health from teens to old age. The first time something goes wrong, the comparison isn't "what's normal for a 67-year-old" — it's "what's normal for you a year ago." Early detection becomes the default, not a screening pass.
Trials currently centralize for data integrity reasons — you go to the academic medical center because that's where the trial lives. With substrate: trials come to you. The site is your home; the data integrity is mathematical. Trials reach populations they currently can't (rural, mobility-limited, undocumented).
Sequencing on commodity hardware writes to your substrate. Researchers request access; you grant or deny per study; nobody else holds your sequence. Pharmacogenomics, oncology, rare disease — all become tractable without the privacy bargain consumer DNA tests currently impose.
Your medical history, signed on your hardware, can be inherited by your children with your consent — family medical history becomes a real artifact instead of "what I remember Mom saying." Hereditary conditions, allergies, medication reactions: all carry forward as a signed record, not as anecdote.
Sense + Reflex on commodity hardware closes the loop on diabetes, hypertension, heart failure, COPD. Continuous sensing, sub-second intervention (medication, prompt, alert), all signed and reviewable by the care team without anyone in the loop. Outcomes improve at a fraction of current care-management cost.
If your full medical history is on your substrate, switching insurers stops being a 90-day administrative nightmare. The records that drive risk-rating are yours to share. Underwriting becomes a math function on a signed record. Job-locked insurance ends not because of policy change but because of substrate change.
"Why isn't the system catching X earlier?" answers today: "no provider sees the whole picture." With substrate, the picture lives with the patient and any provider can run prevention algorithms against it. Independent prevention services become viable; consumers can shop on quality rather than network.
Free clinics, mobile units, FQHCs, refugee health programs all run substrates that produce signed records the patient carries. The undocumented immigrant who has been in the US for 20 years walks into an ER with two decades of signed medical history. The rural Mississippian whose hospital closed still has every prior record. Equity becomes a substrate property, not a policy aspiration.
The price point doesn't just democratize tools. It re-distributes who can afford to deliver care at institutional standards.
Today, the difference between an academic medical center and a rural FQHC isn't medical knowledge — it's the cost of the data infrastructure surrounding the knowledge. EHR licenses, interoperability fees, compliance overhead, audit logging. These cost so much that they're a structural barrier to entry for low-resource delivery.
When the substrate runs on commodity hardware, the infrastructure barrier collapses. A nurse-practitioner-led clinic in a town of 800 can run on the same substrate Cleveland Clinic does. Same records, same continuity, same audit-grade trail.
The historical analogue: when DNA sequencing dropped from $10M/genome (2001) to $200/genome (today), it didn't just make sequencing cheaper — it made a generation of researchers who couldn't have justified the cost do the work anyway. Same shape here. Medical-record infrastructure at commodity-hardware cost makes a generation of providers who currently can't afford the EHR tax deliver care at full-system rigor.
Medicine has been waiting for the substrate to catch up.
It finally has.
Every reform conversation in healthcare for the past thirty years — interoperability, patient empowerment, value-based care, continuous monitoring, equitable access — ends with "if only the records system would let us." The records system has been the constraint. Move the records to the patient, on a substrate that keeps up with the clinic, and the constraints fall away.